This section of the Zynex Medical InvestorRoom houses up to date financial reporting information and interactive tools to provide you with the resources you need to manipulate and understand our current financial standing. 

Please note:  All data in this section is provided by a 3rd party provider and may be delayed up to 20 minutes.  Zynex Medical assumes no responsibility for the accuracy of this data and provides it for informational purposes only.

NASDAQZYXI
Beta0.82
Shares Outstanding34.8M
Average Volume (10 days)170.5K
Qtrly Dividend (Ann. Yield)-- (--)

Per Share Data

Earnings (TTM)$0.16
Sales (TTM)$2.55
Book Value (MRQ)$1.61
Cash Flow (TTM)($0.15)
Cash (MRQ)$0.96

Analyst Views

Current Mean RecommendationBuy
Strong Buy3
 
Buy0
 
Hold3
 
Underperform0
 
Sell0
 

Recent Insider Transactions

Daniel J. Moorhead
Chief Financial Officer
(2,314)
Dispose
Jun 7, 2021
Daniel J. Moorhead
Chief Financial Officer
5,000
Acquire
Jun 5, 2021
Anna Lucsok
COO - Zynex Medical, Inc.
701
Acquire
May 5, 2021
Daniel J. Moorhead
Chief Financial Officer
1,754
Acquire
May 5, 2021
Daniel J. Moorhead
Chief Financial Officer
(350)
Dispose
May 5, 2021

Recent SEC Filings

Insider Buy/Sell
Jun 14, 2021
Amended Insider Buy/Sell
Jun 11, 2021
Insider Buy/Sell
Jun 8, 2021
Company Events
May 25, 2021
Insider Buy/Sell
May 6, 2021